Reliefband, a wearable technology developer for preventing and treating nausea and vomiting symptoms, has launched Reliefband Sport, a new IPX7-designated waterproof wearable therapeutic device.
Offering user-controlled therapy the device prevents and treats nausea and vomiting associated with motion sickness, morning sickness from pregnancy, anxiety, hangovers, physician-diagnosed migraines, chemotherapy, and as an adjunct to antiemetics in treating post-operative nausea.
Reliefband Sport includes a built-in rechargeable battery that, when fully charged, will last 30 hours on the medium intensity level. Six intensity levels can be toggled allowing users to find the precise setting that’s optimal for their needs. With the Sport model’s smart sensing technology, the device will turn off after 60 seconds if skin contact is not detected to preserve battery life.
Rich Ransom, president and CEO at Reliefband, said: “Reliefband is one of the only solutions that prevents nausea and vomiting before it begins while also being effective after symptoms have already occurred. With Reliefband Sport, we went even further by introducing an all-new waterproof model that provides 30 hours of use on a full charge. The Sport model’s flex fit comfort band can also be customised with a variety of interchangeable bands, all while still delivering the same all-natural, long-lasting nausea prevention and treatment that Reliefband is known for.”
The result of more than 20 years of clinical research, Reliefband’s FDA-cleared, patented technology uses programmed pulses with a highly specific waveform, frequency, and intensity to stimulate the median nerve on the underside of the wrist. This activity uses the body’s natural neural pathways to block waves of nausea produced by the stomach.
Reliefband’s drug-free therapy is effective and without the side effects associated with anti-nausea medicine such as drowsiness and constipation. All Reliefband devices can be used either before or after nausea and vomiting symptoms start and can be left on as long as symptoms subsist.
